JGIA
DXCM icon

Jackson Grant Investment Advisers’s DexCom DXCM Stock Holding History

Jackson Grant Investment Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12
Closed -$1.66K – 400
2024
Q1 		$1.66K Hold
12
– – ﹤0.01% 372
2023
Q4 		$1.49K Hold
12
– – ﹤0.01% 369
2023
Q3 		$1.12K Hold
12
– – ﹤0.01% 379
2023
Q2 		$1.54K Hold
12
– – ﹤0.01% 386
2023
Q1 		$1.39K Buy
+12
New +$1.34K ﹤0.01% 422

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jackson Grant Investment Advisers's DXCM Position: Q2 2024 in Review

Jackson Grant Investment Advisers sold out of DexCom (DXCM) in Q2 2024, closing a stake of 12 shares — an estimated $1.66K sold.

Jackson Grant Investment Advisers first reported a position in DXCM in Q1 2023 and held it in 5 quarters. The position peaked at $1.66K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Jackson Grant Investment Advisers reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 12 DexCom shares in Q2 2024, an estimated $1.66K.
  • Jackson Grant Investment Advisers first reported a position in DexCom in Q1 2023 and held it in 5 quarters.
  • Jackson Grant Investment Advisers's DexCom position peaked at $1.66K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2024, filed 16 Jul 2024.